Oscotec/ADEL Initiates First-in-Human Dosing in Ph1 of Anti-MTBR Tau Antibody ADEL-Y01 In Alzheimer's Disease

/PRNewswire/ -- Oscotec Inc. and ADEL Inc. announced the dosing of the first healthy participant in its first-in-human study of ADEL-Y01 for the treatment of...

Related Keywords

Pangyo ,Kyonggi Do ,South Korea ,Janssen Pharma ,Seungyong Yoon ,Kyung Hoon Hwang ,Taeyoung Yoon ,University Of Ulsan College Medicine ,Yuhan Corp ,Asan Medical Center ,Prnewswire Oscotec Inc ,Oscotec Inc ,Mild Cognitive Impairment ,Clinical Investigation ,Ulsan College ,Hoon Hwang ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Pharmaceuticals ,Biotechnology ,Clinical Trials Amp Medical Discoveries ,